Bad news for saxagliptin?
Recently, the FDA said it will review possible heart risks associated with saxagliptin, a widely used diabetes drug.
Read More
Recently, the FDA said it will review possible heart risks associated with saxagliptin, a widely used diabetes drug.
Read More
A diabetes epidemic is upon us, despite improved knowledge and therapy on this disease. The recently published 6th edition of the International Diabetes Federation Atlas provides some alarming figures.
Read More
It is an exciting time as risk-based monitoring (RBM) application grows throughout industry.
Read More
Most of us at industry would be more familiar with traditional contract research organizations (CROs) than academically led research organizations (AROs). The broad range of organizations that carry the term AROs does lead to confusion, and its not until fairly recently that the definition of an ARO within a clinical trial setting was well defined. […]
Read More
The George Clinical Data Management group offers end to end Data Management services for phase I – IV and post-marketing clinical trials, as well as tailored services for academic research trials. Our goal is to provide flexible solutions for our customers and we offer a range of database options to suit study requirements. Fully validated […]
Read More
